Back to results
US 2024/0173062 A1Published application
Neuromodulation for metabolic conditions or syndromes
AssigneeMedtronic Ireland Manufacturing Unlimited Company
InventorsBobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai
Life of this patent
Estimating the term…
Abstract
According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
Claims17
1-2. (canceled)
A method comprising:
- positioning at least one therapeutic element of a neuromodulation device within a hepatic artery of a subject;
- causing at least one of energy or a chemical agent to be delivered by the at least one therapeutic element to nerves surrounding the hepatic artery of the subject, wherein the at least one of the energy or the chemical agent is sufficient to ablate at least some of the nerves surrounding the hepatic artery of the subject;
- positioning the at least one therapeutic element of the neuromodulation device within a renal artery;
- and
- causing the at least one of energy or the chemical agent to be delivered by the at least one therapeutic element to nerves surrounding the renal artery, wherein the at least one of the energy or the chemical agent is sufficient to ablate at least some of the nerves surrounding the renal artery.
2 more elements
Dependencies are inferred from the claim text.